XTL BIOPHARMACEUTICALS LTD (XTLB) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Dilution Analysis

Low Risk

Limited dilution potential

Last updated: April 30, 2025

Risk Assessment Details

Potential Dilution: 0.0% of current shares

Recent Dilution: 0% (2 years)

Historical Dilution Factor: minimal recent dilution

Outstanding Shares

880M

Potential Supply

Additional shares possible

Splits

None

Past 2 years

Summary

XTLB currently has 881M outstanding shares. with minimal authorized share overhang for future dilution. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding
Apr 30, 2025	20-F filing \| 881.4M shares outstanding	880M
Apr 30, 2024	20-F filing \| 544.9M shares outstanding	540M
Mar 22, 2023	20-F filing \| 544.9M shares outstanding	540M
Mar 30, 2022	20-F filing \| 544.9M shares outstanding	540M
Jun 02, 2021	POS AM filing: This is a filing for ADSs offered representing ordinary shares issuable upon exercise of warrants from previous private placements.	730M
Mar 15, 2021	20-F filing \| 514.2M shares outstanding	510M
Mar 12, 2020	20-F filing \| 514.2M shares outstanding	510M

Back to XTLB Details